These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31935471)

  • 1. Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics.
    Vaidya B; Kulkarni NS; Shukla SK; Parvathaneni V; Chauhan G; Damon JK; Sarode A; Garcia JV; Kunda N; Mitragotri S; Gupta V
    Int J Pharm; 2020 Mar; 577():118995. PubMed ID: 31935471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC).
    Parvathaneni V; Kulkarni NS; Chauhan G; Shukla SK; Elbatanony R; Patel B; Kunda NK; Muth A; Gupta V
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111139. PubMed ID: 32600728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC).
    Parvathaneni V; Goyal M; Kulkarni NS; Shukla SK; Gupta V
    Pharm Res; 2020 Jun; 37(7):123. PubMed ID: 32514688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer.
    Shukla SK; Kulkarni NS; Farrales P; Kanabar DD; Parvathaneni V; Kunda NK; Muth A; Gupta V
    Pharm Res; 2020 Mar; 37(3):67. PubMed ID: 32166411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity.
    Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated VRB plus quinacrine cationic liposomes for treating non-small cell lung cancer.
    Li XT; Zhou ZY; Jiang Y; He ML; Jia LQ; Zhao L; Cheng L; Jia TZ
    J Drug Target; 2015 Apr; 23(3):232-43. PubMed ID: 25417934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer.
    Wang X; Parvathaneni V; Shukla SK; Kulkarni NS; Muth A; Kunda NK; Gupta V
    Int J Biol Macromol; 2020 Dec; 164():638-650. PubMed ID: 32693132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.
    Vaidya B; Parvathaneni V; Kulkarni NS; Shukla SK; Damon JK; Sarode A; Kanabar D; Garcia JV; Mitragotri S; Muth A; Gupta V
    Int J Biol Macromol; 2019 Feb; 122():338-347. PubMed ID: 30401652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation.
    Kulkarni NS; Vaidya B; Parvathaneni V; Bhanja D; Gupta V
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-synergistic combination of Erlotinib and Quinacrine for non-small cell lung cancer (NSCLC) therapeutics - Evaluation in biologically relevant in-vitro models.
    Kulkarni NS; Vaidya B; Gupta V
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111891. PubMed ID: 33579503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)-development and in-vitro efficacy.
    Elbatanony RS; Parvathaneni V; Kulkarni NS; Shukla SK; Chauhan G; Kunda NK; Gupta V
    Drug Deliv Transl Res; 2021 Jun; 11(3):927-943. PubMed ID: 32557351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect
    Li F; Wang Y; Chen WL; Wang DD; Zhou YJ; You BG; Liu Y; Qu CX; Yang SD; Chen MT; Zhang XN
    Theranostics; 2019; 9(20):5886-5898. PubMed ID: 31534526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-conjugated bovine serum albumin nanoparticles as a tamoxifen tumor-targeted delivery system.
    Gharbavi M; Johari B; Eslami SS; Mousazadeh N; Sharafi A
    Cell Biol Int; 2020 Dec; 44(12):2485-2498. PubMed ID: 32841441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of inhalable transferrin functionalized amodiaquine nanoparticles - Efficacy in Non-Small Cell Lung Cancer (NSCLC) treatment.
    Parvathaneni V; Shukla SK; Kulkarni NS; Gupta V
    Int J Pharm; 2021 Oct; 608():121038. PubMed ID: 34438008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation.
    Kunda NK; Alfagih IM; Dennison SR; Tawfeek HM; Somavarapu S; Hutcheon GA; Saleem IY
    Pharm Res; 2015 Apr; 32(4):1341-53. PubMed ID: 25297713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry powder pulmonary delivery of cationic PGA-co-PDL nanoparticles with surface adsorbed model protein.
    Kunda NK; Alfagih IM; Dennison SR; Somavarapu S; Merchant Z; Hutcheon GA; Saleem IY
    Int J Pharm; 2015 Aug; 492(1-2):213-22. PubMed ID: 26169146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue.
    Abbas Y; Azzazy HM; Tammam S; Lamprecht A; Ali ME; Schmidt A; Sollazzo S; Mathur S
    Colloids Surf B Biointerfaces; 2016 Oct; 146():19-30. PubMed ID: 27244047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.
    Girotra P; Singh SK
    Pharm Res; 2016 Jul; 33(7):1682-95. PubMed ID: 27003706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration.
    Wang G; Kucharski C; Lin X; Uludağ H
    J Drug Target; 2010 Sep; 18(8):611-26. PubMed ID: 20158316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating.
    Wang G; Siggers K; Zhang S; Jiang H; Xu Z; Zernicke RF; Matyas J; Uludağ H
    Pharm Res; 2008 Dec; 25(12):2896-909. PubMed ID: 18709447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.